Grifulvin V Product Description
Grifulvin V is an anti-fungal agent for oral administration. Grifulvin V tablets are used to fight superficial infectious diseases of varying severity, caused by pathogenic genera of fungi.
Grifulvin V is prescribed to patients, who were victimized by various types of ringworm (dermatophytosis) infections, including ringworm of the scalp, body, nails, inner thighs, buttocks, groin (and sometimes the scrotum), tinea pedis (athlete's foot), ringworm of the beard and tinea unguium (dermatophytic onychomycosis).
The anti-fungal agent Grifulvin V enters the protozoa cells and blocks their ability to reproduce. The course of treatment with Grifulvin V should be extended until the moment, when the new tissue replaces damaged or diseased tissue.
For treatment of mild to moderate superficial pathologies, caused by pathogenic fungi, the patients are prescribed with Grifulvin V 375mg per day in single or divided doses. For controlling a more serious condition, or if the infection is difficult to eradicate, the patients are prescribed with Grifulvin V 750mg per day in two divided doses.
If you have not taken the prescribed dosage of Grifulvin V, please, take this anti-fungal agent as soon as you remember. You should not take the anti-fungal medication, if it is almost time for your next scheduled Grifulvin V dose. Do not take a double dose to make up for the missed dose.
Genera of fungi, responsible for the disease, should be determined before you start the anti-fungal therapy. The recommended treatment duration with Grifulvin V tablets ranges from 2 to 8 weeks, and can be prolonged up to 6 months, if necessary.
The anti-fungal medication Grifulvin V should be stored in an original container in a dry, dark place at controlled room temperature of 15°C to 30°C.
Grifulvin V Safety Information
Grifulvin V is only intended for oral administration and should not be used for prevention of fungal infections. Grifulvin V can cause sun allergy, so patients should avoid prolonged exposure to sunlight. Grifulvin V can modify the effect of birth control pills, so mechanical contraception methods are recommended within the treatment with this antifungal medication. Grifulvin V is contraindicated in pregnancy, or to the patients, who are planning to become pregnant within 30 days after the treatment discontinuation.
All information materials about treatment of fungal infections are provided for general informational purposes only. In no way this information is intended to be a substitute for a professional medical advice of a mycologist or other qualified health professional. The online pharmacy will not be liable for any direct, indirect, or other damages, arising from using this information about the antifungal medication, provided in the review on Grifulvin V.
Grifulvin V Side Effects
Like most anti-fungal compounds, Grifulvin V is usually well tolerated by patients. Examples of common undesirable effects of Grifulvin V include: headache, mental confusion, hypersensitivity reactions (incl. skin rashes and hives), neuritis, nausea, vomiting or leucopenia. Grifulvin V pills may rarely cause angioneurotic edema, paresthesia, oral candidiasis, albuminuria, limitations of routine activities performance, granulocytopenia or insomnia.